{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:47:55Z","timestamp":1795128475448,"version":"4.10.3"},"reference-count":93,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nagasaki University Doctoral Program for World-leading Innovative and Smart Education for Global Health, KENKYU SHIDO KEIHI"},{"DOI":"10.13039\/501100023693","name":"Vaccine Impact Modelling Consortium","doi-asserted-by":"publisher","award":["INV-034281"],"award-info":[{"award-number":["INV-034281"]}],"id":[{"id":"10.13039\/501100023693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJPR22R3"],"award-info":[{"award-number":["JPMJPR22R3"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K17329"],"award-info":[{"award-number":["JP22K17329"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National University of Singapore Start-Up Grant"},{"name":"Centers for Disease Control and Prevention Safety and Healthcare Epidemiology Prevention Research Development program","award":["200-2016-91781"],"award-info":[{"award-number":["200-2016-91781"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2476523","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:33:40Z","timestamp":1741253620000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response"],"prefix":"10.1080","volume":"24","author":[{"given":"Sol","family":"Kim","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyolim","family":"Kang","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Skrip","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Sahastrabuddhe","sequence":"additional","affiliation":[{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"International Vaccine Institute","place":["Seoul, South Korea"]},{"name":"Yonsei University","place":["Seoul, South Korea"]},{"name":"Universit\u00e9 Jean Monnet","place":["Saint-\u00c9tienne, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausraful","family":"Islam","sequence":"additional","affiliation":[{"name":"icddr,b","place":["Dhaka, Bangladesh"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Mok","family":"Jung","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill","place":["Chapel Hill, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Vesga","sequence":"additional","affiliation":[{"name":"UK Health Security Agency","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Endo","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"National University of Singapore","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Edmunds","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Abbas","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, UK"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Nagasaki University","place":["Nagasaki, Japan"]},{"name":"Public Health Foundation of India","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421701"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04379-2"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1307.061128"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01875\u201317"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1202.051247"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy612"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad467"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1410.060507"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/647951"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1012.040452"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00262-7"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011617"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2204.151747"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2102.141433"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16020171"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.818545"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805376"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5470.1432"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64493-8"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010690"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftz023"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-5-142"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-05-0310"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1026"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1323"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03838"},{"key":"e_1_3_6_29_1","unstructured":"Study details | a phase 1 study to evaluate safety & immunogenicity of rVSV-nipah virus vaccine candidate PHV02 in healthy adult subjects | ClinicalTrials.Gov [Internet]. [cited 2024 Jul 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05178901?cond=Nipah%20Virus%20Infection&intr=Vaccine&rank=4"},{"key":"e_1_3_6_30_1","unstructured":"ISRCTN. ISRCTN87634044: a study of a new vaccine against Nipah virus in adults aged 18 to 55 years [internet]. [cited 2024 Jul 20]. Available from: https:\/\/www.isrctn.com\/ISRCTN87634044"},{"key":"e_1_3_6_31_1","unstructured":"Study details | safety and immunogenicity of a nipah virus vaccine | ClinicalTrials.Gov [Internet]. [cited 2024 Jul 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04199169?cond=Nipah%20Virus%20Infection&intr=Vaccine&rank=1"},{"key":"e_1_3_6_32_1","unstructured":"Study details | dose escalation open-label clinical trial to evaluate safety tolerability and immunogenicity of a Nipah virus (NiV) mRNA vaccine mRNA-1215 in healthy adults | ClinicalTrials.Gov [Internet]. [cited 2024 Jul 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05398796?cond=Nipah%20Virus%20Infection&intr=Vaccine&rank=3"},{"key":"e_1_3_6_33_1","unstructured":"Study details | study to evaluate safety and immunogenicity of a prime-boost regimen of rVSV-nipah virus vaccine candidate PHV02 in healthy adult subjects | ClinicalTrials.Gov [Internet]. [cited 2024 Jul 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06221813?cond=Nipah%20Virus%20Infection&page=1&rank=2"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1216225"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00592-9"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00284-w"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz391"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010658"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007462"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.016"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-237"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2003.131159"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00842"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772864"},{"key":"e_1_3_6_45_1","unstructured":"Frenck R Naficy A Feser J et al. Safety and immunogenicity of a nipah virus vaccine (hev-sg-v) in adults: a single-centre randomised Observer-Blind placebo-controlled phase 1 study Available from: https:\/\/ssrn.com\/abstract=4845156"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.027"},{"key":"e_1_3_6_47_1","unstructured":"Pathogens prioritization: a scientific framework for epidemic and pandemic research preparedness [Internet]. World Health Organization. [cited 2024 Aug 12]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/consultation-rdb\/prioritization-pathogens-v6final.pdf?sfvrsn=c98effa7_7&download=true"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.009"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00602-20"},{"key":"e_1_3_6_50_1","unstructured":"WHO-Listed authority (WLA) [Internet]. [cited 2024 Dec 17]. Available from: https:\/\/www.who.int\/initiatives\/who-listed-authority-reg-authorities"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae017"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad352"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxz012"},{"key":"e_1_3_6_54_1","unstructured":"CEPI Equitable Access Framework [Internet]. CEPI; 2023. Available from: https:\/\/static.cepi.net\/downloads\/2024-03\/CEPI_Equitable%20Access%20Framework_May%202023_0.pdf"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32621-6"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006037"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-1015"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.21037\/jphe.2017.02.03"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00038-4"},{"key":"e_1_3_6_60_1","unstructured":"FDA. Research C for DE and. Table of surrogate endpoints that were the basis of drug approval or licensure. [Internet]. 2022 [cited 2024 Nov 9]."},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00261-9"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215302"},{"key":"e_1_3_6_63_1","unstructured":"FDA. Vaccines. 2024. [Internet] [cited 2024 Sep 4]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30923-3"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/82_2021_239"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2003.004440"},{"key":"e_1_3_6_67_1","unstructured":"FDA. Animal Rule Approvals [Internet]. 2023 [cited 2024 Aug 19]. Available from: https:\/\/www.fda.gov\/drugs\/nda-and-bla-approvals\/animal-rule-approvals"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.01.004"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/npjvaccines.2016.13"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2129"},{"key":"e_1_3_6_71_1","unstructured":"Price A Sizemore D Hassell T et al. Nipah virus assays and animal models for vaccine development [Internet]. 2021. Available from: https:\/\/media.tghn.org\/medialibrary\/2021\/02\/Nipah_Virus_Assays_and_Animal_Models_for_Vaccine_Development_final.pdf"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4444"},{"key":"e_1_3_6_73_1","unstructured":"European Medicines Agency. Guideline on clinical evaluation of vaccines [Internet]. 2023 [cited 2024 Jul 1]. Available from: https:\/\/www.ema.europa.eu\/en\/clinical-evaluation-new-vaccines-scientific-guideline"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002873"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1669"},{"key":"e_1_3_6_76_1","unstructured":"PRIME: priority medicines | European medicines Agency. [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/prime-priority-medicines"},{"key":"e_1_3_6_77_1","unstructured":"Exceptional circumstances | European medicines agency (EMA) [Internet]. [cited 2024 Aug 24]. Available from: https:\/\/www.ema.europa.eu\/en\/glossary-terms\/exceptional-circumstances"},{"key":"e_1_3_6_78_1","unstructured":"Directorate General of Drug Administration (DGDA) [Internet]. [cited 2024 Jul 16]. Available from: https:\/\/dgda.gov.bd\/site\/view\/policies\/http%3A%2F%2Fdgda.gov.bd%2Fsite%2Fview%2Fpolicies%2FPolicies"},{"key":"e_1_3_6_79_1","unstructured":"Central Drugs Standard Control Organization [Internet]. [cited 2024 Jul 16]. Available from: https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/biologicals\/Vaccines\/"},{"key":"e_1_3_6_80_1","unstructured":"IXCHIQ. FDA [Internet]. 2024 [cited 2024 Jul 29]."},{"key":"e_1_3_6_81_1","unstructured":"Ixchiq | European Medicines Agency [Internet]. [cited 2024 Jul 29]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ixchiq"},{"key":"e_1_3_6_82_1","unstructured":"Health Canada. Regulatory decision summary for ixchiq [Internet]. [cited 2024 Dec 15]. Available from: https:\/\/dhpp.hpfb-dgpsa.ca\/review-documents\/resource\/RDS1719926004455"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126483"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160173"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003764"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00641-4"},{"key":"e_1_3_6_87_1","unstructured":"WHO Target Product Profile for Nipah virus Vaccine [Internet]. 2017 [cited 2024 Jul 6]. Available from: https:\/\/www.who.int\/csr\/research-and-development\/priority_disease_list_review_short_summary_25Jan2017.pdf"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03108-x"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.08.061"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.019"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.09.044"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003794"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03232-y"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01775-0"},{"key":"e_1_3_6_95_1","unstructured":"WHO. Diagnostics laboratory emergency use listing [Internet]. [cited 2024 Dec 18]. Available from: https:\/\/www.who.int\/teams\/regulation-prequalification\/eul"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2476523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:47:33Z","timestamp":1765522053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2476523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2476523"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2476523","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}